
The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.
The company has petitioned FDA for a qualified health claim for whole grains and certain food products containing whole grains.
ConAgra Foods Inc. (Omaha, NE) has petitioned FDA for a qualified health claim relating to
ConAgra’s petition-including details about the proposed claim and scientific references-can be downloaded at the link above.






